StockSelector.com
  Research, Select, & Monitor Friday, October 19, 2018 4:38:18 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Sorrento Therapeutics, Inc.$3.38($.18)(5.06%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Sorrento Therapeutics, Inc. has an overall rank of 6266 out of 7267 stocks based on 10 positive rankings and 6 negative rankings.

Positive Rankings
Historic Revenue Growth
Sorrento Therapeutics rank is 16
PEGValue
Sorrento Therapeutics has a PEG Value of $8.24. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 131.37% in the next year. Among companies with a PEG Value above the current stock price, Sorrento Therapeutics is ranked 324.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Sorrento Therapeutics is ranked 632.
Low Put/Call
Sorrento Therapeutics has a low Put/Call ratio of 0.52 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sorrento Therapeutics is ranked 1311.
Oversold Stochastics
Sorrento Therapeutics rank is 1682
Price-to-Book
Sorrento Therapeutics rank is 1729
Debt-to-Equity
Sorrento Therapeutics rank is 2202
Highest ROA
Sorrento Therapeutics rank is 2284
Highest Net Margin
Sorrento Therapeutics rank is 2334
Highest ROE
Sorrento Therapeutics rank is 2722
Negative Rankings
Negative EPS Growth
Sorrento Therapeutics rank is 3
High vPut/Call
Sorrento Therapeutics has a high Put/Call ratio of 5.60 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Sorrento Therapeutics is ranked 192.
90 Day Loss
Sorrento Therapeutics rank is 249
10 Day Loss
Sorrento Therapeutics rank is 656
Down EPS Surprise
Sorrento Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Sales
Sorrento Therapeutics rank is 2269







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.